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Abstract
Introduction Severe sepsis is a dreaded consequence of infection and necessitates intensive care
treatment. Severe sepsis has a profound impact on mortality and on hospital costs, but recent
incidence data from The Netherlands are not available. The purpose of the present study was to
determine the prevalence and incidence of severe sepsis occurring during the first 24 hours of
admission in Dutch intensive care units (ICUs).
Methods Forty-seven ICUs in The Netherlands participated in a point prevalence survey and included
patients with infection at the time of ICU admission. Clinical symptoms of severe sepsis during the first
24 hours of each patient's ICU stay were recorded and the prevalence of severe sepsis was calculated.
Then, the annual incidence of severe sepsis in The Netherlands was estimated, based on the
prevalence, the estimated length of stay, and the capacity of the participating ICUs relative to the
national intensive care capacity.
Results The participating ICUs had 442 beds available for admissions, which was estimated to be
42% of the national ICU capacity. At the time of the survey, 455 patients were currently admitted and
151 were included in the analysis; 134 (29.5%) patients met criteria for severe sepsis. The most
common failing organ system was the respiratory system (90%), and most patients were admitted
following surgery (37%) and were admitted because of acute infection (62%). The most prevalent
source of infection was the lung (47%). The estimated duration of ICU stay for severe sepsis patients
was 13.3 ± 1.1 days.
Conclusion The annual number of admissions for severe sepsis in Dutch ICUs was calculated at 8643
± 929 cases/year, which is 0.054% of the population, 0.61% of hospital admissions and 11% of ICU
admissions.
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Introduction
Severe sepsis is a major complication of infection, and is trig-
gered by a systemic inflammatory and coagulation reaction.
The mortality rate from severe sepsis is high. In a recent
update on the epidemiology of sepsis, Angus and Wax [1]
cited several studies that reported mortality rates of 20–52%.
A multicentre study conducted in 170 intensive care units
(ICUs) in France [2] found 28-day mortality rates of 56% and
60% in patients with severe sepsis and culture-negative
severe sepsis, respectively. It has also been estimated that the
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R154number of people who died after severe sepsis in 1995 in the
USA was equal to the number of deaths after acute myocardial
infarction [3].
Patients suffering from severe sepsis require intensive care
and account for a large part of ICU resource consumption. It
was demonstrated by Bakker and coworkers [4,5] that 52–
59% of an ICU budget was allocated to sepsis and septic
shock patients, but that those patients constituted only 24%
of the ICU population. Moreover, new therapeutic strategies
for the treatment of severe sepsis may carry considerable
acquisition costs and further increase treatment expenses. In
the narrow margins of current health care budgets, economi-
cal considerations are likely to be taken into account when
medical decisions are made. Data on incidence and preva-
lence are therefore essential if we are to appreciate the scope
of a health problem, both medically and macroeconomically.
The incidence of severe sepsis in ICUs in The Netherlands has
been estimated in a number of studies. In 1986 Verbrugh and
coworkers [6] identified 5.4 cases of bacteraemia with clinical
symptoms for every 1000 hospital admissions in two general
hospitals, and in 1993 Kieft and colleagues [7] found an inci-
dence of sepsis syndrome in a Dutch university hospital of
1.36% of all hospital admissions. In 1994 the National Institute
for Public Health and the Environment reported 4.8 cases of
sepsis registered as first or second diagnoses for every 1000
hospital admissions on the basis of National Medical Registra-
tion in The Netherlands [8]. However, the Institute noted that
this number was most likely an underestimation because sep-
sis may go unregistered.
More recent studies on the incidence of severe sepsis in The
Netherlands are lacking. Therefore, the present cross-sec-
tional prevalence survey was conducted in order to determine
the prevalence and extrapolate the incidence of severe sepsis
in Dutch ICUs.
Methods
General study design
The design of the survey was developed within the context of
the development of clinical guidelines for the application of
activated protein C [9]. The aim of the study was to determine
the number of severe sepsis cases that one can annually
expect to be eligible for therapies specifically indicated for
severe sepsis, other than organ replacement or life-sustaining
therapies. Some of the choices made in the study design (e.g.
inclusion of patients with microbiologically proven as well as
clinically suspected infections rather than proven infections
only, and the restriction of the survey to intensive care wards
only) are a consequence of this clinical practice orientated
study objective.
All heads of Dutch ICUs were invited by letter to participate in
the survey. All patients present on the ICU or admitted for any
length of time during a 24-hour period – between 08:00 on
Tuesday 11 December 2001 and 08:00 on Wednesday 12
December 2001 – were considered for inclusion. A case
report form (CRF) was completed for every patient with a con-
firmed or strongly suspected infection at the time they were
admitted to the ICU (Table 1), as determined by the first ques-
tion in the CRF (Appendix 2). The CRF only inquired about
clinical symptoms within the first 24 hours of a patient's ICU
stay, thereby selectively aiming to determine only the preva-
lence of community-acquired and hospital-acquired severe
sepsis. Including ICU-acquired severe sepsis in this cross-
sectional prevalence study would have required a more com-
plex study design, more intensive training, and greater invest-
ments of time from the participating ICUs, which were beyond
the scope of the survey.
Both patients who were already present at the start of the
study as well as newly admitted patients during the study
period were considered for inclusion. The reason for this was
that severe sepsis is difficult to measure in a prevalence survey
because it is a syndrome; it is not a condition that a patient
have or not have. When a patient is admitted to the ICU with
severe sepsis, it may well be that all criteria defining severe
sepsis are no longer present by the next day, but the patient
may stay for another fortnight until they are sufficiently recov-
ered to be transferred to a general ward or discharged. During
that time, the patient does not meet the criteria for severe sep-
sis but is still present on the ICU for treatment of resulting
pathologies. In order to ensure that these patients would be
captured in the survey, the patient CRF explicitly asked the
person responsible for its completion to answer the questions
based on the first 24 hours of admission only.
A brief questionnaire was developed to capture several rele-
vant ICU characteristics. The CRFs and questionnaires sent to
the participating ICUs were collected and evaluated. The def-
initions of sepsis, severe sepsis and septic shock, which rep-
resent increasingly severe stages in the sepsis cascade, were
derived from the American College of Chest Physicians/Soci-
ety of Critical Care Medicine guidelines (Table 1) [10]. In this
report we treated these stages as successive subgroups of
the initial population, which means that, for example, septic
shock patients form a subset of the severe sepsis population
rather than a separate population.
Questionnaires and case report forms
Intensive care unit questionnaire
The ICU questionnaire consisted of two parts: the first ques-
tioned the total number of ICU beds in the unit and the number
of beds that were closed because of understaffing or for other
reasons (Appendix 1). The theoretical availability of beds in
every ICU was calculated by subtracting the number of closed
beds from the total number of beds. The second part of the
questionnaire recorded the total number of patients present in
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number of patient-days covered by the survey.
Case report form
Only patients with a confirmed or strongly suspected infection
at the time of their admission were included in the present
study. The CRF consisted of 30 closed questions, divided into
four subsets (Appendix 2). The first referred to the status of the
patient at the time of ICU admission and collected age, sex,
date and time of ICU admission, previous location (i.e. to
determine whether they had been transferred from another
department/hospital or whether their admission to the ICU
was primary), reason for ICU admission and source of infec-
tion. The second part collected information regarding the pres-
ence of comorbidities (including chronic organ failure). In the
third part the four systemic inflammatory response syndrome
(SIRS) criteria were scored for the first 24 hours of ICU admis-
sion, and the fourth part collected data regarding acute organ
failure during the first 24 hours of ICU stay. Criteria for the lat-
ter were adopted from the PROWESS (Human Activated Pro-
tein C Worldwide Evaluation in Severe Sepsis) study and
were described on the CRF (Table 1) [11]. The CRF was
straightforward and the items pertained to standard and objec-
tively measurable parameters (e.g. body temperature, blood
concentrations and heart rate). Therefore, no problems with
the comprehension of the questionnaire or interobserver relia-
bility were expected, and no pilot study was conducted.
Participation
We invited 103 ICUs in The Netherlands to participate in the
prevalence survey after telephone contact to identify a contact
person. The request was accompanied by a description of the
study design. Fifty-six ICUs agreed to participate. Forty-seven
participating ICUs returned the completed CRFs and ques-
tionnaires. The reported data were entered into a Microsoft
Excel database, and double entry was performed to certify the
data.
Method of incidence calculation
A prevalence survey offers a static picture of a situation, such
as the number of patients in an ICU because of severe sepsis.
However, we were also interested in severe sepsis patients
Table 1
Definitions of sepsis
Criteria/definition
SIRS Fever or hypothermia (body temperature < 36°C or > 38°C)
Tachycardia (> 90 beats/min)
Tachypnoea (> 20 breaths/min or PaCO2 < 4.3 kPa (32 mmHg) during spontaneous breathing or the need for artificial 
respiration)
Leucocytes > 12000/mm3 or < 4000/mm3 or > 10% immature neutrophils
Sepsis Presence of a confirmed or strongly suspected infection and occurrence of at least two SIRS criteria during the first 24 
hours of ICU admission
Severe sepsis Sepsis in combination with the occurrence of at least one failing organ system (defined below) within the first 24 hours of 
ICU admission
Septic shock Sepsis in combination with the occurrence of cardiovascular organ failure and metabolic dysfunction (defined below) during 
the first 24 hours of ICU admission
Acute organ failure CNS dysfunction: acute deterioration of neurological condition not attributable to start of sedation or CNS disease in the 24 
hours before admission or during the period of observation
Cardiovascular system dysfunction: systolic blood pressure ≤ 90 mmHg or mean arterial pressure ≤ 70 mmHg for 1 hour, 
despite adequate fluid resuscitation, or the need to administer vasopressors in order to maintain systolic blood pressure ≥ 
90 mmHg or mean arterial pressure ≥ 70 mmHg
Kidney failure: urine output < 0.5 ml/kg per hour for at least 1 hour, despite adequate fluid resuscitation, or serum creatinine 
≥ 177 µmol/l not attributable to chronic kidney failure
Respiratory system dysfunction: a ratio of PaO2 to FiO2 < 26.6 kPa if source of infection was not pulmonary and < 33.2 kPa 
if infection source was pulmonary, or if mechanical or noninvasive artificial respiration was indicated because of clinical 
respiratory insufficiency within the first 24 hours of admission
Haematological dysfunction: platelet count < 80,000/mm3, or a decrease of at least 50% in the 2 days preceding admission
Metabolic dysfunction: metabolic acidosis (pH ≤ 7.30 or base deficit ≥ 5.0 mmol/l) in association with a plasma lactate level 
> 3.0 mmol/l
Liver dysfunction: bilirubin > 43 µmol/l, or ALT (SGPT) > 50 U, or PTT more than 1.5 times normal or INT > 1.5 in the 
absence of systemic anticoagulant agents
ALT, alanine aminotransferase; PaCO2, arterial carbon dioxide tension; CNS, central nervous system; FiO2, fractional inspired oxygen; ICU, 
intensive care unit; SGPT, serum glutamate-pyruvate transaminase; SIRS, systemic inflammatory response syndrome.
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olated the information from our prevalence series of cases to
annual incidence estimates.
Prevalence, incidence and duration
A dependent relationship exists between prevalence, inci-
dence and duration of a disease [12]:
Pn = Ij × Ei(D)  Equation 1
where Pn is the prevalence unit in numbers of persons, Ij is the
incidence rate in persons (new cases)/time, and Ei(D) is the
expected value of the duration of the condition in a distribution
of durations obtained from an incidence (i) series of cases.
Ei(D) can also be interpreted as the sample mean duration Di
from an incidence series.
In the equation, Ij is the unknown factor that we were interested
in. Prevalence (Pn) and duration (Ei[D]) were retrieved from the
survey results in the following manner.
The prevalence of severe sepsis patients in the survey was
defined as the total number of patients present on the ICU dur-
ing the study time interval that had all symptoms of severe sep-
sis during the first 24 hours of their stay. These first 24 hours
of stay may have been in the past (i.e. outside the study period)
but it was assumed that the reason these patients were still
present on the ICU was the episode of severe sepsis in the
past. These patients were therefore counted as prevalent
severe sepsis patients.
Because the objective of the investigation was to determine
the number of patients annually admitted to the ICU with
severe sepsis, Pn in Eqn 1 refers to the prevalent number of
patients occupying an ICU bed, and Di actually refers to the
duration of ICU stay associated with severe sepsis rather than
the duration of severe sepsis itself. Pn in Eqn 1 was calculated
by extrapolating the prevalent number of patients in the survey
(Ps) to the whole country, using the number of ICU beds as a
distributive key (R = number of ICU beds in survey/number of
ICU beds in The Netherlands). The annual incidence (Ij) was
therefore calculated from the survey results as follows:
Ij = Pn/(Ei[D]) = (Ps/R)/Di  Equation 2
It was not possible to derive the duration of stay (Di) directly
from the prevalence study, because one only knows how long
the patient has been in the ICU until the point prevalence sur-
vey (the 'duration to date') and not how much longer the
patient will stay. The duration of stay can, however, be derived
from the duration to-date. Freeman and Hutchison [12]
described how both duration of stay from an incidence series
of cases and duration to date from a prevalence series of
cases of a similar patient population are, in theory, geometri-
cally distributed with similar means. Therefore, we inserted the
observed duration to date into the software @RISK (for Win-
dows) in order to check whether the distribution was geomet-
rical, and calculated the mean, which was subsequently
entered into Eqn 1 as Di.
From the point prevalence survey, not only the number of prev-
alent but also the number of incident patients was known (i.e.
the patients who were newly admitted during the study period
and developed symptoms of severe sepsis in the next 24
hours). This survey incidence (Ids), however small, was used
for a second calculation of the annual incidence according to
Eqn 3, extrapolating the 1-day incidence in the survey to a
national estimate through the distributive key:
Ij = (Ids/R) × 365  Equation 3
Statistics
Descriptive outcomes are presented in terms of means and
standard deviations. When estimating the incidence, preva-
lence and length of stay, means are surrounded by standard
errors.
Results
Questionnaire and case report form
Four departments from university hospitals and 43 depart-
ments from general hospitals returned the completed ques-
tionnaires and CRFs with information on 152 patients for
whom the CRF had been completed (Table 2). Data from one
patient were excluded from further analyses because of miss-
ing information.
Table 2
Characteristics of participating intensive care units
Characteristic Total General hospitals University hospitals
Number of ICU departments 47 43 (91) 4 (9)
Number of admitted patients 455 407 (89) 48 (11)
Number of beds 510 466 (91) 44 (9)
Number of available beds 442 399 (90) 43 (10)
Number of case report forms returned 152 130 (86) 22 (14)
Results are shown for all participating intensive care units (ICUs; total), and subdivided into general and university hospital ICUs (% of total).
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(87%) were available for admission. The remaining beds were
mainly closed because of understaffing of the department.
Three ICU departments specified that their ICU was a com-
bined ICU/cardiac care unit (CCU) department. The beds and
patients that could be attributed to the CCU were excluded
from the calculation of the total number of beds and patients
in this survey. During the prevalence study period, 455
patients were present in the participating ICUs (Table 2).
Evaluation of the 151 CRFs according to the definitions of
sepsis (Table 1) resulted in the estimate that 143 patients in
the prevalence series had sepsis in the first 24 hours of admis-
sion, representing 31% of all ICU patients. In 134 (93%)
cases the sepsis was severe and in 53 cases (37%) the sep-
sis was complicated by cardiovascular and metabolic organ
failure meeting the definition of septic shock. The remaining
eight patients had an infection but fulfilled no more than one
SIRS criterion. If we considered only patients newly admitted
to the ICU during the 24-hour period (the incidence series) we
identified 24 patients with sepsis, 18 (75%) of whom devel-
oped severe sepsis and seven (29%) septic shock.
On average, patients with severe sepsis were 64 ± 15 years
old. Of these patients, 70% were older than 60 years and 44%
were older than 70 years. The ratio of males to females was
1.7. In 121 (90%) of the prevalent patients with severe sepsis,
more than one organ system failed (without being due to
chronic organ failure), with an average of 3.6 ± 1.6 failing
organ systems (Fig. 1). In 121 out of 134 prevalent patients
the respiratory system failed (90%), followed by the cardiovas-
cular system in 97 (72%) and the renal system in 71 patients
(53%: Table 3). Patients with septic shock had on average 4.9
± 1.2 failing organ systems, including the cardiovascular and
metabolic organ systems (Fig. 1). Furthermore, the respiratory
system failed in 49 (92%), the liver in 34 (64%) and the renal
system in 33 (62%) patients (Table 3). Most patients with
severe sepsis in the prevalence series (50 [37%]) were admit-
ted to the ICU from the Department of Surgery, 35 (26%)
patients came from the emergency room, and 20 (15%)
patients were admitted from the Department of Internal Medi-
cine (Table 4). The major cause for ICU admission for severe
sepsis was acute infection in 83 (62%) patients, followed by
acute surgery in 41 (31%).
The most common sites of infection were the lungs (47%) and
the abdomen (34%). In 35 (26%) of the prevalent severe sep-
sis patients respiratory comorbidity was present on admission,
and 32 patients (24%) had a malignancy. Diabetes, chronic
heart failure, a history of cerebrovascular accidents and
chronic kidney failure were seen in many patients. The
distribution of comorbidities in the prevalent patients with sep-
tic shock was similar to that of patients with severe sepsis.
Calculation of annual incidence of severe sepsis
Participation
The exact number of ICU beds in The Netherlands is unknown
because the definition and capacity of hospital beds is not
fixed. A hospital bed can be turned into an ICU bed and back
again, depending on the hospital situation. A recent survey of
the Hospital Building Board conducted among all hospitals in
The Netherlands reported 108 ICU departments in 109
general hospitals and 23 ICUs in nine university hospitals, with
a total capacity of 1041 ICU beds that were available for
admission [13]. Another 148 beds were closed because of
understaffing. The representation of ICUs in our survey was
therefore calculated at 42% (442/1041). This percentage
was used for all further calculations of national incidence and
prevalence numbers.
Annual incidence based on the prevalence series of cases
The distribution of 'duration to date' in severe sepsis patients
was geometric, with a mean of 13.3 ± 1.1 days (Table 5). The
P value of the fit (observed significance level) was 0.9821. The
P value can take values between 0 and 1, and as the P value
approaches 1 there is increasing certainty that the fitted distri-
bution actually generated the data set. As the observed distri-
bution of duration to date fitted a geometric distribution well,
Table 3
Organ failure
Organ system failure Severe sepsis (n = 134) Septic shock (n = 53)
Neurological failure 31 (23) 19 (36)
Cardiovascular failure 97 (72) 53 (100)
Renal failure 71 (53) 33 (62)
Respiratory failure 121 (90) 49 (92)
Haematological failure 31 (23) 18 (34)
Metabolic failure 66 (49) 53 (100)
Liver failure 60 (45) 34 (64)
Number of patients in the point prevalence survey with severe sepsis and/or septic shock with acute organ failure in various organ systems (% of 
patients).
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duration of stay in the study population. The analogously
estimated duration of stay for sepsis patients was 12.7 ± 1.0
days and for shock patients it was 11.6 ± 1.5 days.
Calculation according to Eqn 2 yielded an incidence rate of
9726 ± 1008 patients with sepsis in the ICUs per year, with
8643 ± 929 (89%) of them suffering from severe sepsis and
3932 ± 710 (37%) of them suffering shock (Table 5). The cor-
responding incidence numbers for the Dutch population,
which was 16.1 million in December 2001, are 0.60 ± 0.06
cases of sepsis/1000 inhabitants, 0.54 ± 0.06 cases of
severe sepsis/1000 inhabitants, and 0.24 ± 0.04 cases of
septic shock/1000 inhabitants [14].
The total number of clinical hospital admissions and ICU
admissions in The Netherlands in 2000 were reported to be
1,465,000 and 77,000, respectively, which yields an esti-
mated incidence of severe sepsis in 0.61% of all hospital
admissions and 11% in all ICU admissions [15].
Annual incidence based on the incidence series of cases
A second estimate of the annual incidence was calculated
using Eqn 3 and the number of incident patients in the survey.
The resulting daily incidence was calculated to be 57 ± 10, 42
± 9 and 16 ± 6 for sepsis, severe sepsis and shock, respec-
tively. The corresponding estimates for the annual incidence
were 20,632 ± 3681 for sepsis, 15,474 ± 3309 for severe
sepsis and 6018 ± 2195 for septic shock. Consequently,
according to this calculation 1.1% of all hospital admissions
and 20% of all ICU admissions are of patients with severe
sepsis.
By means of an internal check, we combined Eqn 1 with Eqn
3 and substituted Pn = Ps/R, which yielded an equation that we
could apply to the results of the survey:
Ps = 365 × Ids × Di  Equation 4
Substituting the duration of stay of 13.3 days (expressed in
years), as was estimated from the geometrical mean duration
to date, told us that the expected ratio of prevalent and inci-
dent patients (Ps/Ids) in a 1-day survey is 13.3. In the actual
survey we found a ratio of 134/18 = 7.4, suggesting that the
number of incident patients in our survey was relatively high
and/or the number of prevalent patients relatively low.
Discussion
This survey was conducted to determine the annual incidence
of severe sepsis during the first 24 hours of ICU admission in
The Netherlands. The number of severe sepsis patients in 47
ICUs (42% of total national ICU capacity) was captured in the
24-hour period between 08:00 on 11 December 2001 and
08:00 on 12 December 2001; 134 patients were present in
the ICUs during the study period for treatment of severe sep-
sis, and 18 of these arrived during the study period. We calcu-
lated that the annual number of patients who need ICU
treatment for severe sepsis in The Netherlands is 8643 ± 929,
which was estimated to represent 0.61% of hospital admis-
sions and 11% of ICU admissions. Some considerations
regarding the interpretation of this number are addressed
here.
In 1986, Verbrugh and coworkers [6] found that 0.54% of all
hospital admissions in two general hospitals resulted in sepsis
(defined as bacteraemia with clinical symptoms), and Kieft and
coworkers [7] concluded, from a prospective study conducted
in a university hospital, that sepsis syndrome accounted for
1.36% of all hospital admissions. The incidences of sepsis
and severe sepsis per hospital admission, as calculated from
our survey, were 0.65% and 0.61%, respectively, based on
the prevalence series. These percentages are in the region of
the findings reported by Verbrugh and coworkers, but they are
lower than the incidence found by Kieft and colleagues, which
may be because the latter group used a different definition of
sepsis and admissions in a single university hospital only. The
incidence of severe sepsis, at 11% of ICU admissions, was
similar to the rate reported by Alberti and coworkers [16], who
surveyed 14,364 ICU patients for more than 1 year in ICUs in
several European countries, Canada and Israel. They identified
1634 patients with either severe sepsis or septic shock at
admission. Finfer and coworkers [17] found that 571 ICU
admissions were due to severe sepsis in 5878 consecutive
ICU patients admitted to Australian and New Zealand ICUs.
Figure 1
Failing organ systems. Histogram of the number of failing organ sys-
tems in prevalent patients with severe sepsis (n = 134; light grey) and 
septic shock (n = 53; dark grey). Numbers within bars represent the 
absolute numbers of patients. On average, 3.6 ± 1.6 organ systems 
failed in patients with severe sepsis (mean ± standard deviation) and 
4.9 ± 1.2 in patients with septic shock.
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R159Padkin and coworkers [18] reported a much higher incidence
(27.1%) within the first 24 hours of ICU admission in England,
Wales and Northern Ireland from a retrospective database
analysis, but at a population level the incidence was similar (51
per 100,000 inhabitants). This inconsistency suggests that
ICU admission policy is an important issue to consider when
comparing findings between different institutions or countries.
The median ICU stay in their survey was 3.6 days, which is low
compared with our and previously reported findings [3,19].
Two recent retrospective analyses of discharge databases in
the USA [3,20] also found higher incidence rates by popula-
tion (240–300 per 100,000) and by hospital admission
(2.6%), but in these studies severe sepsis patients were not
defined by American College of Chest Physicians/Society of
Critical Care Medicine guidelines criteria but by ICD-9-CM
(International Classification of Diseases, Ninth revision, Clini-
Table 4
Demographic and clinical characteristics of severe sepsis and/or septic shock patients
Demographic/clinical characteristic Severe sepsis (n = 134) Septic shock (n = 53)
Previous location
Surgery 50 (37) 26 (49)
Internal Medicine 20 (15) 5 (9)
Cardiology 0 0
Neurology 5 (4) 2 (4)
Emergency room 35 (26) 14 (26)
Outside hospital 13 10) 3 (6)
Other 11 (8) 3 (6)
Reason for ICU admission
Acute surgery 41 (31) 20 (38)
Elective surgery 5 (4) 2 (4)
Acute trauma 5 (4) 1 (2)
Acute infection 83 (62) 30 (57)
Source of infection
Lung 63 (47) 22 (42)
Abdomen 45 (34) 20 (38)
Urethra 3 (2) 3 (6)
Central nervous system 2 (1) 1 (2)
Blood 3 (2) 0
Skin 9 (7) 5 (9)
Other 9 (7) 2 (4)
Comorbidities
Diabetes 25 (19) 9 (17)
History of CVA 17 (13) 7 (13)
Malignancy 32 (24) 14 (26)
Heart failure 12 (9) 4 (8)
Respiratory failure 35 (26) 13 (25)
Liver failure 2 (1) 1 (2)
Kidney failure 14 (10) 7 (13)
Previous location, reason for admission, source of infection and presence of comorbidities at the time of intensive care unit (ICU) admission in 
prevalent patients with severe sepsis and septic shock. Number of patients (%). CVA, cerebrovascular accident.
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ered, rather than just ICU patients.
The protocol of the present survey specifically asked partici-
pating ICUs to include only those patients admitted to the ICU
with an infection, which implied that patients with ICU-
acquired severe sepsis were excluded. Although a true esti-
mate of severe sepsis should have included these patients, the
diagnosis of severe sepsis in patients admitted to the ICU with
problems other than infection is very difficult. Current parame-
ters of severe sepsis are probably not sufficiently accurate. In
addition, this would have required consensus about new infec-
tions and newly developed organ dysfunction or worsening
organ dysfunction in all ICUs, which was not possible for the
present study. From the results of the EPIC (European Study
of Prevalence of Infection during Intensive Care) study [21], it
appeared that in 78 Dutch ICUs 17% of the patients had an
ICU infection but only 0.4% of the patients had sepsis result-
ing from an ICU infection. A Dutch surveillance study con-
ducted among 16 ICUs [22], however, found that 8% of
patients who were admitted to the ICU (with or without prior
infection) developed sepsis due to an ICU-acquired infection.
Also, Alberti and coworkers [16] reported that 9.2% of ICU
patients developed ICU-acquired sepsis, severe sepsis, or
septic shock, whereas the rate for community-acquired and
hospital-acquired sepsis, severe sepsis, or septic shock was
17.4%. However, that study did not report the exact method-
ology for determining organ failure developed in the ICU, or
the time frame within which the symptoms of severe sepsis
occurred. Nevertheless, by ignoring sepsis due to ICU-
acquired infections, the present survey probably underesti-
mates the national incidence of cases of severe sepsis.
Moreover, severe sepsis can occur outside ICUs; such cases
were not picked up in the present survey. Angus and cowork-
ers [3] concluded from their retrospective analysis that only
51.1% of severe sepsis patients (defined using ICD-9-CM
codes) received ICU care in the USA, although an additional
17.3% received organ replacement therapy in CCUs or inter-
mediate care units. Because severe sepsis is defined by the
presence of organ failure, ICU admission is almost always
required for organ-replacing therapeutic intervention and spe-
cific treatment for severe sepsis.
Several risk factors for severe sepsis have been identified in
previous studies, including age, sex, comorbidities, and caus-
ative pathogen [3,16]. In extrapolating data from a cross-sec-
tional prevalence survey such as the present one,
consideration of the representativeness of the ICU patients in
the participating ICUs relative to the national case mix of ICU
patients, especially in terms of these risk factors, is important.
Unfortunately, demographic and clinical information was only
collected for the included patients, rather than for all ICU
patients present during the study period. It was therefore not
possible to determine how representative the case mix of ICU
patients in our survey was. On the other hand, the participating
ICUs were estimated to be representative of The Netherlands.
Participating ICUs were distributed evenly over The Nether-
lands, and the representation of both university and general
hospitals was similar (4/9 university hospitals [44%] and 43/
109 general hospitals [39%]). ICUs in Dutch general hospitals
are almost always mixed; only some university hospitals have
separate ICU wards for surgical and medical patients. There-
fore, no bias is expected to have occurred by, for example,
including a disproportionate number of medical ICUs. We
knew the number of ICU beds in our survey and based the esti-
mate of national representation on this number; there was no
national information on the number of beds in general and uni-
versity hospitals separately, and therefore we could not reliably
derive a specified incidence of severe sepsis by type of
hospital.
Although this prevalence survey did not address the length of
stay in the ICU directly, we estimated this duration on the basis
of the duration to date by means of fitting the data to a geo-
metrical distribution, as described by Freeman and Hutchison
[12]. We found a length of stay of 13.3 ± 1.1 days for severe
sepsis patients. This result is consistent with the literature.
Angus and coworkers [3] found a duration of ICU stay of 13.8
± 20.0 days in teaching hospitals and 10.0 ± 13.8 days in
nonteaching hospitals. Edbrooke and coworkers [19] found a
median ICU stay of 16.5 days for patients who developed sep-
sis in the ICU of a university hospital in the UK. We expected
to find increasing lengths of stay with increasing severity of
sepsis, but this was only true for severe sepsis versus sepsis
(13.3 versus 12.7 days). For shock patients, however, we
Table 5
Annual incidence of sepsis in Dutch intensive care units based on survey prevalence
Disorder National prevalence Di (days) Incidence/year1 Incidence/1,000 
inhabitants
Sepsis 337 ± 23 12.7 ± 1.0 9726 ± 1008 0.60 ± 0.06
Severe sepsis 316 ± 23 13.3 ± 1.1 8643 ± 929 0.54 ± 0.06
Septic shock 125 ± 16 11.6 ± 1.5 3932 ± 710 0.24 ± 0.04
Values are expressed as means ± standard error. 1Calculation according to Eqn 2 (see text). Di, duration of intensive care unit stay associated 
with disorder.
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R161found a duration (Di) of 11.6 days, but the prevalent population
of shock patients was rather small to make a powerful fit of the
duration to date (P = 0.69). The method of Freeman and
Hutchison [12] is an indirect method with which to estimate
duration of stay, and data on length of stay should ideally be
extracted from prospective studies.
From the relationship between prevalence and incidence, as
expressed in Eqn 4, we concluded that the ratio of incident
and prevalent patients deviated from theoretical expectation.
An explanation for this trend could be associated with the
study design. In order to identify prevalent patients, the
participating ICUs were required to go through records for all
patients on their ward to determine whether they had an infec-
tion at the time of their admission, and to search the registra-
tion for the presence of SIRS criteria and organ failure during
the first 24 hours of admission. This might have been too time
consuming in some cases, or the specific data may not have
been available. This introduces a negative bias in the number
of prevalent patients found in the survey. On the other hand,
newly admitted patients are likely to be monitored more closely
for infection, SIRS criteria and organ failure when members of
the medical staff are aware that a survey for severe sepsis is
being conducted that day. This makes it conceivable that the
number of incident severe sepsis patients is an overestimation
of the actual daily incidence. Moreover, the number of incident
patients in the survey (i.e. 18) is small and very sensitive to
daily variation, which is also expressed by a large confidence
interval for the estimated daily and annual incidences.
Because we only measured prevalence and incidence over 1
day, there is a good chance that the relatively high number of
incident patients is attributable to coincidence. The annual
incidence of severe sepsis based on the prevalence series of
cases therefore forms a more reliable estimate for future
reference.
The results of the survey were not corrected for any influence
of time, such as the day of the week or the month of the year
on which the survey was conducted. The main reason for this
was the fact that severe sepsis patients are usually acute
cases, and the majority of the population came to the hospital
for acute surgery or acute infection (Table 4). It is not likely that
these acute events differ from weekdays to holidays or week-
ends. Moreover, data on the admission rates for severe sepsis
patients are unavailable, and any correction of the results in
the survey would be as arbitrary as not correcting at all.
The present point prevalence survey was conducted to gain
insight into the current incidence of severe sepsis occurring
within the first 24 hours of ICU admission in The Netherlands.
The results indicate that the national incidence of severe sep-
sis is in the range of 9000 patients per year. This number is
lower (by 50–70%) than the annual incidence of diseases
such as coronary heart disease and cerebrovascular accident,
but it is comparable with the incidence of breast cancer, lung
cancer and Parkinson's disease in The Netherlands. This dem-
onstrates the importance of severe sepsis in terms of public
health, resource allocation in intensive care and, because of
the high overall mortality, causes of death in The Netherlands
[23].
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